General Archive
-
News releasesMRC Technology collaborates with NYU School of Medicine to develop biologics for inflammatory bone disease
MRC Technology and NYU School of Medicine have signed an agreement to develop an antibody for the prevention of inflammatory…
-
News releases
Key US Patents Granted for GPCR-Focused Drug Discovery Platform Arising From Pioneering Research and Translational Expertise at MRC and MRC Technology
Heptares Therapeutics (Heptares) recently announced the grant of multiple key patents in the United States relating to its GPCR-focused drug…
-
News releases
MRC Technology and Shandong International Biotechnology Park (China) to cooperate in new drug for Alzheimer’s
MRC Technology and Shandong International Biotechnology Park (BIOasis) have signed a partnership agreement for the development of a new Alzheimer’s…
-
News releases
Charities pledge to jump start drug development for brain diseases
The Neurodegeneration Medicines Acceleration Programme (Neuro-MAP), led by medical research charity MRC Technology, will see charities and funding bodies identify…
-
News releases
MRC Technology and EMBLEM collaborate to streamline drug development
The initiative will focus on identification of novel druggable targets in the field of small molecules and antibodies, and collaborating…
-
Articles & blogs
Global Drug Development Alliance in Nature Biotechnology
MRC Technology’s Director of Drug Discovery, Justin Bryans, is quoted in a Nature Biotechnology article about the Global Drug Development…
-
News releases
New postpartum haemorrhage drug discovery project launched
A collaboration between MRC Technology and Dr Andrew Blanks at the University of Warwick has been launched to develop inhibitors…